CTA-Sticky-button.png clinicaltrialsyearbook+button

Highlight from 2017

Represented on this year’s programme were some of Europe’s foremost medical device manufacturers. Over the course of two days, senior-level decisions makers came together to discuss some of the most pressing challenges in the outsourcing of medical device trials.

Delegates also had the unique opportunity to receive an up-to-date review of the new medical device regulatory changes made to the new guidance document 2.7.1, addressing how daily clinical practices and outsourcing models will be changed.

Exciting new additions to the programme this year included discussions around clinical reimbursement and post-market surveillance with representatives from global companies.